Ignite Creation Date:
2025-12-24 @ 11:44 PM
Ignite Modification Date:
2026-01-04 @ 7:27 PM
Study NCT ID:
NCT02991651
Status:
TERMINATED
Last Update Posted:
2025-05-14
First Post:
2016-12-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of IRX4204 With Erlotinib in Previously Treated Advanced NSCLC
Sponsor:
Io Therapeutics
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-12-07
Start Date Type:
ACTUAL
Primary Completion Date:
2025-05-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-05-09
Completion Date Type:
ACTUAL
First Submit Date:
2016-12-07
First Submit QC Date:
None
Study First Post Date:
2016-12-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-09
Last Update Post Date:
2025-05-14
Last Update Post Date Type:
ACTUAL